User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Oesophageal cancer studies in the Caspian littoral of Iran: some residual results, including opium use as a risk factor.

  1. Autrup, Cancer Res., 42, 934 (1982)
  2. Autrup, Cancer Res., 42, 1307 (1982)
  3. and , The GLIM System, Release 3. Numerical Algorithms Group, Oxford (1978).
  4. Castonguay, Proc. nat. Acad. Sci. (Wash.), 80, 6694 (1983)
  5. , and , Antipyrine halflife of the population in the high esophageal cancer incidence area in northern China. In: Proceedings of the 13th International Cancer Congress, Seattle, Washington USA, Sept. 8–15, 1982, Excerpta Medica, Amsterdam (1983).
  6. Chang, Life Sci., 22, 855 (1978)
  7. , , , and , Use of drugs in the evaluation of carcinogen metabolism in man. In: and (eds.), Screening tests in chemical carcinogenesis, IARC Scientific Publications No. 12, IARC, Lyon (1976).
  8. Conney, Fed. Proc., 36, 1647 (1977)
  9. Cook-Mozaffari P J, Azordegan F, Day N E, Ressicaud A, Sabai C, Aramesh B, Oesophageal cancer studies in the Caspian Littoral of Iran: Results of a case-control study, 10.1038/bjc.1979.54
  10. Crespi, Lancet, 11, 217 (1979)
  11. Antipyrine metabolite profile as a tool in the assessment of the activity of different drug oxidizing enzymes in man. Docioral thesis, State University of Leiden, Leiden (1980).
  12. , , and , The possible role of opium and tobacco pyrolysates in oesophageal cancer. In: (ed.), Carcinogens and mutagens in the environment, Vol. III: Naturally occurring compounds, pp. 59–71, CRC Press, Boca Raton (1983).
  13. , , , , , , , , , , , , and , Characterization and identification of six mutagens in opium pyrolysates implicated in oesophageal cancer in Iran. Mutation Res. in press (1985).
  14. Hewer, Lancet, 11, 494 (1978)
  15. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER. Annual Report 1983, pp. 41–43, IARC, Lyon (1983).
  16. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER. Annual Report 1984, pp. 41–42, IARC, Lyon (1984).
  17. IRAN/IARC STUDY GROUP, J. nat. Cancer Inst., 59, 1127 (1977)
  18. Kalamegham R., Krishnaswamy K., Krishnamurthy S., Bhargava R. N. K., Metabolism of drugs and carcinogens in man: Antipyrine elimination as an indicator, 10.1002/cpt197925167
  19. , and , Epidemiology of oesophageal cancer with special reference to nutritional studies among the Turkoman of Iran. In: Advances in modern human nutrition, Pathotox, New York (1980).
  20. , , and , The negligible role of alcohol and tobacco in the aetiology of oesophageal cancer in Iran-A case-Control study. In: (ed.), Prevention and detection of cancer, Part II: Detection, pp. 1149–1159, Marcel Dekker, New York (1978).
  21. Mahboubi E, Kmet J, Cook P J, Day N E, Ghadirian P, Salmasizadeh S, Oesophageal Cancer Studies in the Caspian Littoral of Iran: The Caspian Cancer Registry, 10.1038/bjc.1973.138
  22. Malaveille, Carcinogenesis., 3, 557 (1982)
  23. O'neill, Int. J. Cancer, 26, 617 (1980)
  24. Perry, Carcinogenesis, 4, 227 (1983)
  25. Roberfroid, Chem. biol. Interact., 47, 175 (1983)
  26. Sotaniemi, Europ. J. Drug Metab. Phamcokinet., 1, 39 (1973)
  27. Tschanz, Cancer Res., 37, 3881 (1977)
  28. Vessel, Environ. Hlth. Perspect., 20, 161 (1977)
Bibliographic reference Ghadirian, P ; Stein, G F ; Gorodetzky, C ; Roberfroid, Marcel ; Mahon, G A ; et. al. Oesophageal cancer studies in the Caspian littoral of Iran: some residual results, including opium use as a risk factor.. In: International journal of cancer. Journal international du cancer, Vol. 35, no. 5, p. 593-7 (1985)
Permanent URL http://hdl.handle.net/2078.1/25100